{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T00:17:45Z","timestamp":1776557865896,"version":"3.51.2"},"reference-count":63,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.jocn.2012.05.024","type":"journal-article","created":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T21:01:52Z","timestamp":1349125312000},"page":"13-16","source":"Crossref","is-referenced-by-count":41,"title":["Lamotrigine in epilepsy, pregnancy and psychiatry \u2013 a drug for all seasons?"],"prefix":"10.1016","volume":"20","author":[{"given":"Frank J.E.","family":"Vajda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seetal","family":"Dodd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Horgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2012.05.024_b0005","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/0140-6736(92)91207-O","article-title":"Lamotrigine","volume":"339","author":"Brodie","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2012.05.024_b0010","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1528-1157.1986.tb03573.x","article-title":"Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action","volume":"27","author":"Leach","year":"1986","journal-title":"Epilepsia"},{"key":"10.1016\/j.jocn.2012.05.024_b0015","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1111\/j.1528-1157.1991.tb05883.x","article-title":"Clinical pharmacology of lamotrigine","volume":"32","author":"Peck","year":"1991","journal-title":"Epilepsia"},{"key":"10.1016\/j.jocn.2012.05.024_b0020","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1528-1157.1986.tb03536.x","article-title":"Acute effects of lamotrigine (BW430C) in persons with epilepsy","volume":"27","author":"Binnie","year":"1986","journal-title":"Epilepsia"},{"key":"10.1016\/j.jocn.2012.05.024_b0025","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2125.1986.tb05249.x","article-title":"The effect of lamotrigine, a novel anticonvulsant, on interictal spikes in patients with epilepsy","volume":"22","author":"Jawad","year":"1986","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jocn.2012.05.024_b0030","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0920-1211(90)90099-H","article-title":"A randomised double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures","volume":"7","author":"Loiseau","year":"1990","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.jocn.2012.05.024_b0035","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1212\/WNL.43.11.2284","article-title":"Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. U.S. Lamotrigine Protocol 0.5 Clinical Trial Group","volume":"43","author":"Matsuo","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2012.05.024_b0040","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1528-1157.1994.tb02920.x","article-title":"Lamotrigine therapy for partial seizures: a multicenter, placebo-controlled, double-blind, cross-over trial","volume":"35","author":"Messenheimer","year":"1994","journal-title":"Epilepsia"},{"key":"10.1016\/j.jocn.2012.05.024_b0045","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1528-1157.1993.tb02417.x","article-title":"Outcomes of add-on treatment with lamotrigine in partial epilepsy","volume":"34","author":"Smith","year":"1993","journal-title":"Epilepsia"},{"key":"10.1016\/j.jocn.2012.05.024_b0050","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1528-1157.1998.tb01332.x","article-title":"Double-blind, placebo-controlled, crossover study of lamotrigine in treatment-resistant generalised epilepsy","volume":"39","author":"Beran","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.jocn.2012.05.024_b0055","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0022-3476(95)70047-1","article-title":"Lamotrigine for the treatment of epilepsy in childhood","volume":"127","author":"Besag","year":"1995","journal-title":"J Pediatr"},{"key":"10.1016\/j.jocn.2012.05.024_b0060","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1177\/0883073897012001081","article-title":"Lamotrigine in absence and primary generalized epilepsies","volume":"12","author":"Mikati","year":"1997","journal-title":"J Child Neurol"},{"key":"10.1016\/j.jocn.2012.05.024_b0065","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1056\/NEJM199712183372504","article-title":"Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group","volume":"337","author":"Motte","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2012.05.024_b0070","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/0140-6736(92)91632-I","article-title":"Lamotrigine in primary generalised epilepsy","volume":"339","author":"Timmings","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2012.05.024_b0075","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1159\/000116849","article-title":"Lamotrigine as an add-on drug in the management of Lennox-Gastaut syndrome","volume":"32","author":"Timmings","year":"1992","journal-title":"Eur Neurol"},{"key":"10.1016\/j.jocn.2012.05.024_b0080","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0920-1211(96)01007-8","article-title":"Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group","volume":"26","author":"Brodie","year":"1997","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.jocn.2012.05.024_b0085","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1586\/ern.09.136","article-title":"Drug interactions involving the new second- and third-generation antiepileptic drugs","volume":"10","author":"Johannessen Landmark","year":"2010","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.jocn.2012.05.024_b0090","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(07)60461-9","article-title":"The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial","volume":"369","author":"Marson","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2012.05.024_b0095","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(07)60460-7","article-title":"The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial","volume":"369","author":"Marson","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2012.05.024_b0100","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-2125.1985.tb05120.x","article-title":"Lamotrigine (BW430C), a potential anticonvulsant. Effects on the central nervous system in comparison with phenytoin and diazepam","volume":"20","author":"Cohen","year":"1985","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jocn.2012.05.024_b0105","series-title":"Use of lamotrigine in the treatment of bipolar disorder. Annual Meeting New Research Program and Abstracts","author":"Weisler","year":"1994"},{"key":"10.1016\/j.jocn.2012.05.024_b0110","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1176\/ajp.153.9.1236a","article-title":"Antidepressant effects of lamotrigine in rapid cycling bipolar disorder","volume":"153","author":"Calabrese","year":"1996","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jocn.2012.05.024_b0115","doi-asserted-by":"crossref","first-page":"522","DOI":"10.4088\/JCP.v58n1202","article-title":"Lamotrigine in rapid-cycling bipolar disorder","volume":"58","author":"Fatemi","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jocn.2012.05.024_b0120","first-page":"65","article-title":"Lamotrigine in the treatment of resistant bipolar disorder","volume":"21","author":"Kotler","year":"1998","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.jocn.2012.05.024_b0125","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4088\/JCP.v60n0203","article-title":"A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group","volume":"60","author":"Calabrese","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jocn.2012.05.024_b0130","unstructured":"GlaxoSmithKline. Lamictal full prescribing information; 2011."},{"key":"10.1016\/j.jocn.2012.05.024_b0135","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1399-5618.2010.00836.x","article-title":"Lamotrigine versus lithium as maintenance treatment in bipolar I disorder: an open, randomized effectiveness study mimicking clinical practice. The 6th trial of the Danish University Antidepressant Group (DUAG-6)","volume":"12","author":"Licht","year":"2010","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.jocn.2012.05.024_b0140","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4088\/JCP.v64n0906","article-title":"A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder","volume":"64","author":"Calabrese","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jocn.2012.05.024_b0145","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4088\/JCP.08m04152","article-title":"Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial","volume":"70","author":"van der Loos","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jocn.2012.05.024_b0150","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/00004714-200012000-00004","article-title":"A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders","volume":"20","author":"Frye","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.jocn.2012.05.024_b0155","doi-asserted-by":"crossref","first-page":"403","DOI":"10.4088\/JCP.v64n0407","article-title":"A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes","volume":"64","author":"Barbosa","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jocn.2012.05.024_b0160","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/YIC.0b013e328014823d","article-title":"Lithium versus lamotrigine augmentation in treatment resistant unipolar depression: a randomized, open-label study","volume":"22","author":"Schindler","year":"2007","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.jocn.2012.05.024_b0165","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.biopsych.2006.12.031","article-title":"Six-month prospective life charting of mood symptoms with lamotrigine monotherapy versus placebo in rapid cycling bipolar disorder","volume":"63","author":"Goldberg","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jocn.2012.05.024_b0170","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1016\/S0924-977X(99)00025-5","article-title":"Lamotrigine and the treatment of mania in bipolar disorder","volume":"9","author":"Berk","year":"1999","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.jocn.2012.05.024_b0175","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1399-5618.2005.00235.x","article-title":"Safety and tolerability of emerging pharmacological treatments for bipolar disorder","volume":"7","author":"Dunner","year":"2005","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.jocn.2012.05.024_b0180","first-page":"270","article-title":"A preliminary study of lamotrigine in the treatment of affective instability in borderline personality disorder","volume":"24","author":"Reich","year":"2009","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.jocn.2012.05.024_b0185","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/0269881105051540","article-title":"Lamotrigine treatment of aggression in female borderline-patients: a randomized, double-blind, placebo-controlled study","volume":"19","author":"Tritt","year":"2005","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.jocn.2012.05.024_b0190","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/JCP.0b013e3181a443d0","article-title":"A double-blind randomized trial of mood stabilizer augmentation using lamotrigine and valproate for patients with schizophrenia who are stabilized and partially responsive","volume":"29","author":"Glick","year":"2009","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.jocn.2012.05.024_b0195","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/YIC.0b013e328329c7b5","article-title":"Lamotrigine in the treatment of binge-eating disorder with obesity: a randomized, placebo-controlled monotherapy trial","volume":"24","author":"Guerdjikova","year":"2009","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.jocn.2012.05.024_b0200","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1360-0443.2005.00983.x","article-title":"A medication screening trial evaluation of reserpine, gabapentin and lamotrigine pharmacotherapy of cocaine dependence","volume":"100","author":"Berger","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.jocn.2012.05.024_b0205","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1023\/A:1010799115457","article-title":"Lamotrigine therapy for autistic disorder: a randomized, double-blind, placebo-controlled trial","volume":"31","author":"Belsito","year":"2001","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.jocn.2012.05.024_b0320","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/JCP.0b013e31820428e1","article-title":"Lamotrigine in the immediate treatment of outpatients with depersonalization disorder without psychiatric comorbidity: randomized, double-blind, placebo-controlled study","volume":"31","author":"Aliyev","year":"2011","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.jocn.2012.05.024_b0215","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0006-3223(99)00011-6","article-title":"A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder","volume":"45","author":"Hertzberg","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jocn.2012.05.024_b0220","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1479-828X.2011.01359.x","article-title":"The prescribing of antiepileptic drugs for pregnant Australian women","volume":"52","author":"Vajda","year":"2012","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.jocn.2012.05.024_b0225","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(11)70107-7","article-title":"Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry","volume":"10","author":"Tomson","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jocn.2012.05.024_b0230","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1468-1331.2006.01359.x","article-title":"Foetal malformations and seizure control: 52months data of the Australian Pregnancy Registry","volume":"13","author":"Vajda","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jocn.2012.05.024_b0235","doi-asserted-by":"crossref","first-page":"581","DOI":"10.5694\/j.1326-5377.2007.tb01421.x","article-title":"Monitoring antiepileptic drug therapy with serum level measurements","volume":"187","author":"Vajda","year":"2007","journal-title":"Med J Aust"},{"key":"10.1016\/j.jocn.2012.05.024_b0240","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0378-4347(99)00043-2","article-title":"Determination of lamotrigine in human plasma by high-performance liquid chromatography","volume":"727","author":"Angelis-Stoforidis","year":"1999","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"10.1016\/j.jocn.2012.05.024_b0245","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jocn.2011.08.003","article-title":"Teratogenicity of the newer antiepileptic drugs\u2013the Australian experience","volume":"19","author":"Vajda","year":"2012","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.jocn.2012.05.024_b0250","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1089\/jwh.2010.2616","article-title":"Breastfeeding: a clinical imperative","volume":"20","author":"Brenner","year":"2011","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.jocn.2012.05.024_b0255","doi-asserted-by":"crossref","first-page":"70","DOI":"10.18773\/austprescr.2008.041","article-title":"Antiepileptic drugs in pregnancy and lactation","volume":"31","author":"Lander","year":"2008","journal-title":"Aust Prescriber"},{"key":"10.1016\/j.jocn.2012.05.024_b0260","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1528-1157.1999.tb00807.x","article-title":"Lamotrigine-associated rash: risk\/benefit considerations in adults and children","volume":"40","author":"Guberman","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.jocn.2012.05.024_b0265","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1399-5618.2011.00923.x","article-title":"Multisite, open-label, prospective trial of lamotrigine for geriatric bipolar depression: a preliminary report","volume":"13","author":"Sajatovic","year":"2011","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.jocn.2012.05.024_b0270","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1023\/A:1019627618972","article-title":"Fatal progressive hepatic necrosis associated with lamotrigine treatment: a case report and literature review","volume":"47","author":"Overstreet","year":"2002","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jocn.2012.05.024_b0275","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1212\/01.WNL.0000130195.62670.A6","article-title":"Lamotrigine-induced seizure aggravation and negative myoclonus in idiopathic rolandic epilepsy","volume":"63","author":"Cerminara","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2012.05.024_b0280","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/00002018-199818040-00004","article-title":"Safety review of adult clinical trial experience with lamotrigine","volume":"18","author":"Messenheimer","year":"1998","journal-title":"Drug Saf"},{"key":"10.1016\/j.jocn.2012.05.024_b0285","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1212\/WNL.59.1.79","article-title":"Aggravation of partial seizures by antiepileptic drugs: is there evidence from clinical trials?","volume":"59","author":"Somerville","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2012.05.024_b0290","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/ana.410430406","article-title":"Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy","volume":"43","author":"Isojarvi","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2012.05.024_b0295","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1046\/j.1528-1157.2001.28899.x","article-title":"On the association between valproate and polycystic ovary syndrome","volume":"42","author":"Genton","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.jocn.2012.05.024_b0300","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1212\/01.WNL.0000098936.46730.64","article-title":"Effect of epilepsy and antiepileptic drugs on male reproductive health","volume":"62","author":"Isojarvi","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2012.05.024_b0305","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1046\/j.1528-1157.2001.0420081002.x","article-title":"Hormone profiles in young adults with epilepsy treated with sodium valproate or lamotrigine monotherapy","volume":"42","author":"Stephen","year":"2001","journal-title":"Epilepsia"},{"issue":"Suppl. 1","key":"10.1016\/j.jocn.2012.05.024_b0310","first-page":"196","article-title":"Utility of plasma lamotrigine concentrations. Concept of the plasma therapeutic range for individual patients. Annual Scientific Meeting of European Neurological Society, Milan, June 5\u201310 1999","volume":"246","author":"Vajda","year":"1999","journal-title":"J Neurol"},{"key":"10.1016\/j.jocn.2012.05.024_b0315","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.eplepsyres.2005.06.004","article-title":"Individual changes in lamotrigine plasma concentrations during pregnancy","volume":"65","author":"Petrenaite","year":"2005","journal-title":"Epilepsy Res"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586812003529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586812003529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T10:57:53Z","timestamp":1594724273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586812003529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0967586812003529"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2012.05.024","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}